Qing Qing Yi
Directeur/Membre du Conseil chez BEIGENE, LTD.
Fortune : 201 895 $ au 30/04/2024
Profil
Qing Qing Yi is currently serving as the Vice Chairman at Hisun Pfizer Pharmaceuticals Co., Ltd.
since 2017.
Additionally, Mr. Yi holds the position of Independent Non-Executive Director at BeiGene Ltd.
since 2014, Non-Executive Director at JD Health International, Inc. since 2020, and Partner at Hillhouse Capital Group Ltd.
since 2005.
Previously, Mr. Yi served as the Chairman at Genor Biopharma Holdings Ltd.
from 2018 to 2021 and as a Non-Executive Director at Shanghai Junshi Biosciences Co., Ltd.
from 2016 to 2021.
Mr. Yi also held director positions at Gossamer Bio, Inc. and Hibercell, Inc. Mr. Yi obtained an MBA from the University of Southern California in 2003 and completed undergraduate studies at Shanghai Maritime University in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEIGENE LTD
0,00% | 19/04/2024 | 16 692 ( 0,00% ) | 201 895 $ | 30/04/2024 |
Postes actifs de Qing Qing Yi
| Sociétés | Poste | Début |
|---|---|---|
| BEIGENE, LTD. | Directeur/Membre du Conseil | 01/10/2014 |
| JD HEALTH INTERNATIONAL INC. | Directeur/Membre du Conseil | 21/08/2020 |
Hillhouse Capital Group Ltd.
 Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/01/2005 |
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | 15/12/2017 |
Anciens postes connus de Qing Qing Yi
| Sociétés | Poste | Fin |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Président | 02/11/2021 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Directeur/Membre du Conseil | 29/06/2021 |
| GOSSAMER BIO, INC. | Directeur/Membre du Conseil | 19/12/2018 |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de Qing Qing Yi
| Shanghai Maritime University | Undergraduate Degree |
| University of Southern California | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| JD HEALTH INTERNATIONAL INC. | Health Services |
| Entreprise privées | 3 |
|---|---|
Hillhouse Capital Group Ltd.
Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Finance |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |
